Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma: Ratain MJ, Eisen T. Stadler WM, Flaherty KT, Kaye SB, Rosner GL, Gore M, Desai A, Patnaik A, Xiong HQ, Rowinsky E, Abbruzzese JL, Xia C, Simantov R, Schwartz B. O’Dwyer PJ, University of Chicago, Chicago, IL

✍ Scribed by Paul Russo

• Book ID: 116955984
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 36 KB
• Volume: 24
• Category: Article
• ISSN: 1078-1439
• DOI: 10.1016/j.urolonc.2006.08.006